Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)

Clinical trial NCT01947959 · COMPLETED

Trial details

NCT number: NCT01947959
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Venous Thrombosis Pulmonary Embolism Atrial Fibrillation Acute Coronary Syndrome

Start date: 2011-12-22
Primary completion: 2020-09-30
Enrollment: 665533

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.